Dr. Beti Thompson

For the Media

Dr. Beti Thompson

Dr. Beti Thompson is a member of Fred Hutch's Public Health Sciences Division and associate director of the Health Disparities Research Center. Dr. Thompson's research focuses on community approaches to reducing cancer and health disparities in minority and underserved populations.

Resources for more information

Overview of Beti Thompson's Research Focus
Community approaches to reducing cancer and other health disparities in minority and other underserved populations, both in the US and abroad.

Beti Thompson - Brief Curriculum Vitae
Appointments, affiliations and researcher interests

Health Disparities Research Center
The Health Disparities Research Center (HDRC) is designed to enhance collaboration with and among Fred Hutch and Seattle Cancer Care Alliance programs and create a forum that enables health disparities' researchers to work together.

Public Health Sciences Division
Using large populations as their laboratory, public-health researchers look for links between cancer and its possible triggers, from diet and lifestyle to environmental and genetic factors.  


Hutch Team

For more information or to arrange an interview, please contact Fred Hutch at (206) 667-2210 or email our media relations team.



Download photos and view a video of Dr. Beti Thompson

Related Stories

At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch’s pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation’s first National Cancer Institute-funded cancer prevention research program, as well as the clinical coordinating center of the Women’s Health Initiative and the international headquarters of the HIV Vaccine Trials Network.